The “Bomb Cyclone” whipped the East Coast Thursday, with winds of up to 60 mph and snow falling at the rate of two inches per hour. One meteorologist told Cheddar the arctic blast dubbed “Grayson” is even more powerful than 1993’s “Storm of the Century.” “Fortunately is located just off-shore, so we are not seeing the very worst of it,” said Bob Henson, blogger at Weather Underground. “It’s also moving so quickly that the snowfall amounts, the totals, are not going to be as high as they were in that 1993 storm. However, the winds are going to be hellacious.” The 1993 storm caused the equivalent of $9.3 billion in damages from the Deep South through the East Coast. But this year’s blizzard, despite its ominous-sounding descriptor, may be less scary than it sounds. The National Oceanic and Atmospheric Administration notes the term “Bomb Cyclone” comes from the term “bombogenesis,” which describes pressures that drop to at least 24 millibars over 24 hours. Still, Henson points out, Grayson has already claimed some victims. “We just had a couple of fatalities in North Carolina of people out on the roads and their trucks slid of the roads,” he said. He added that the cold temperatures can also be deadly. In order to stay safe, Henson suggests staying in a warm place, avoiding travel, and keeping off the road as the most important steps. For full interview [click here](https://cheddar.com/videos/climate-changes-role-in-winter-storm-grayson).

Share:
More In Science
As U.S. Opioid Crisis Worsens, Price of Life-Saving Drug Naloxone Skyrockets
Jill Wagner and Baker Machado break down the state of the Opioid Crisis in the U.S. The CDC reported a 30% increase in overdose deaths from 2020 to 2021, but in recent months pharmaceutical companies have drastically raised the price of Naloxone or 'Narcan,' affecting the response of community harm prevention groups.
Regeneron Joins Battle Against COVID-19, Releases Stats on New COVID Treatment
The world hit a grim milestone on Monday, with COVID-19 cases surpassing a quarter of a billion worldwide. As cases increase, the fight to beat the virus continues as well, with a number of medical breakthroughs coming out over the last few months in the form of pills from Pfizer and Merck. Regeneron is now the latest company to join the fight, recently releasing new data on a covid antibody cocktail. Professor Peter Pitts, former FDA Associate Commissioner and the founder of the Center for Medicine in the Public Interest breaks down the differences between the 3 treatments and why vaccines are still among the fire line of defense.
Legal Questions Swirl as States Push Back Against Biden COVID Vaccine Mandate
The Biden Administration's mandate for COVID vaccinations by large employers has been put on hold by federal courts as GOP-led states and some businesses push back on the order's legality. Jonathan Adler, a law professor at Case Western Reserve University, joined Cheddar to discuss the legal challenges to implementing such mandates through OSHA (Occupational Safety and Health Administration). "Certainly expanding vaccinations is a good thing, and as vaccination rates go up that's better for all of us," Adler said. "But there are some legal questions about whether or not it's appropriate to use a law about occupational safety and health as the means to do that."
What COVID-19 Vaccines for Kids Might Mean for Fight Against Pandemic
Dr. Robert Frenck, an infectious disease specialist at Cincinnati Children's Hospital, joined Cheddar to talk about the significance of children ages 5-11 being authorized to receive COVID-19 vaccinations. He also discussed schools being cleared to administer vaccines and noted the importance of meeting people where they are rather than forcing them to find the shots. Frenck also said he expects that children under 5 years old will begin getting vaccinations sometime in spring.
Everything You Need to Know About Child Covid-19 Vaccines
A CDC advisory committee as unanimously voted to recommend the Pfizer Covid-19 vaccine in children ages 5 to 11. Dr. Amesh Adalja, Infectious Disease Specialist and Senior Scholar at Johns Hopkins Center for Health Security, joined Cheddar News to discuss.
Load More